UBS Group’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.18K | Sell |
4,627
-36,482
| -89% | -$40.9K | ﹤0.01% | 7877 |
|
|
2025
Q1 | $47.3K | Buy |
41,109
+30,611
| +292% | +$35.2K | ﹤0.01% | 6350 |
|
|
2024
Q4 | $64.1K | Buy |
10,498
+3,294
| +46% | +$20.1K | ﹤0.01% | 5928 |
|
|
2024
Q3 | $119K | Sell |
7,204
-1,203
| -14% | -$19.9K | ﹤0.01% | 5048 |
|
|
2024
Q2 | $57.8K | Sell |
8,407
-4,924
| -37% | -$33.8K | ﹤0.01% | 5439 |
|
|
2024
Q1 | $129K | Buy |
13,331
+131
| +1% | +$1.26K | ﹤0.01% | 4954 |
|
|
2023
Q4 | $110K | Buy |
13,200
+6,199
| +89% | +$51.5K | ﹤0.01% | 4934 |
|
|
2023
Q3 | $58.5K | Sell |
7,001
-955
| -12% | -$7.97K | ﹤0.01% | 5073 |
|
|
2023
Q2 | $73.4K | Buy |
7,956
+3,148
| +65% | +$29.1K | ﹤0.01% | 5181 |
|
|
2023
Q1 | $66.1K | Buy |
4,808
+850
| +21% | +$11.7K | ﹤0.01% | 5163 |
|
|
2022
Q4 | $67.3K | Buy |
3,958
+3,718
| +1,549% | +$63.2K | ﹤0.01% | 5343 |
|
|
2022
Q3 | $5K | Sell |
240
-596
| -71% | -$12.4K | ﹤0.01% | 8093 |
|
|
2022
Q2 | $15K | Sell |
836
-257
| -24% | -$4.61K | ﹤0.01% | 6257 |
|
|
2022
Q1 | $29K | Sell |
1,093
-51,556
| -98% | -$1.37M | ﹤0.01% | 5994 |
|
|
2021
Q4 | $1.55M | Buy |
52,649
+17,908
| +52% | +$526K | ﹤0.01% | 3083 |
|
|
2021
Q3 | $2.28M | Buy |
34,741
+30,739
| +768% | +$2.02M | ﹤0.01% | 2662 |
|
|
2021
Q2 | $333K | Sell |
4,002
-12,259
| -75% | -$1.02M | ﹤0.01% | 4013 |
|
|
2021
Q1 | $1.25M | Buy |
16,261
+16,087
| +9,245% | +$1.23M | ﹤0.01% | 3165 |
|
|
2020
Q4 | $15K | Sell |
174
-5,391
| -97% | -$465K | ﹤0.01% | 6141 |
|
|
2020
Q3 | $411K | Buy |
5,565
+5,230
| +1,561% | +$386K | ﹤0.01% | 3559 |
|
|
2020
Q2 | $24K | Sell |
335
-2,667
| -89% | -$191K | ﹤0.01% | 5585 |
|
|
2020
Q1 | $169K | Sell |
3,002
-4,157
| -58% | -$234K | ﹤0.01% | 4020 |
|
|
2019
Q4 | $273K | Buy |
+7,159
| New | +$273K | ﹤0.01% | 4381 |
|